Evidence map›Paper›PMID 33003939›Full record

ArticleChaos (Woodbury, N.Y.)2020

Power-law distribution in the number of confirmed COVID-19 cases.

Bernd Blasius

Abstract read
In one paragraph

Article in Chaos (Woodbury, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. What is the optimal country for minimum COVID-19 morbidity and mortality rates?Environmental science and pollution research international · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The distribution of COVID-19 mortality.Infectious Disease Modelling · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Power law in COVID-19 cases in China.Journal of the Royal Statistical Society. Series A, (Statistics in Society) · 2022
    Article
  15. Article
  16. Article
  17. Functional observability and target state estimation in large-scale networks.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bernd BlasiusInstitute for Chemistry and Biology of the Marine Environment, University of Oldenburg, 26111 Oldenburg, Germany.ORCID 0000000265581462

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is an emerging respiratory infectious disease caused by the coronavirus SARS-CoV-2. It was first reported on in early December 2019 in Wuhan, China and within three months spread as a pandemic around the whole globe. Here, we study macro-epidemiological patterns along the time course of the COVID-19 pandemic. We compute the distribution of confirmed COVID-19 cases and deaths for countries worldwide and for counties in the US and show that both distributions follow a truncated power-law over five orders of magnitude. We are able to explain the origin of this scaling behavior as a dual-scale process: the large-scale spread of the virus between countries and the small-scale accumulation of case numbers within each country. Assuming exponential growth on both scales, the critical exponent of the power-law is determined by the ratio of large-scale to small-scale growth rates. We confirm this theory in numerical simulations in a simple meta-population model, describing the epidemic spread in a network of interconnected countries. Our theory gives a mechanistic explanation why most COVID-19 cases occurred within a few epicenters, at least in the initial phase of the outbreak. By combining real world data, modeling, and numerical simulations, we make the case that the distribution of epidemic prevalence might follow universal rules.

Indexed as

Models, TheoreticalBetacoronavirusCoronavirus InfectionsCOVID-19HumansPandemicsPneumonia, ViralPopulation DynamicsSARS-CoV-2

Identifiers

PMID33003939
PMCPMC7519452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.